Option Care Health, Inc. (NASDAQ:OPCH) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• Option Care Health, Inc. has received a consensus recommendation of "Moderate Buy" from nine analysts, with an average price target of $35.75.
• Recent insider activity includes Director Timothy P. Sullivan purchasing 20,000 shares and Director Harry M. Jansen Kraemer, Jr. acquiring 36,000 shares at prices around $27.51 and $27.15 per share, respectively.
• Option Care Health reported a quarterly EPS of $0.41, exceeding estimates, with a revenue increase of 15.4% year-over-year, and has established an FY 2025 guidance of 1.650-1.720 EPS.

Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) have been given a consensus rating of "Moderate Buy" by the nine research firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $35.75.

A number of equities analysts have weighed in on OPCH shares. JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Thursday, July 10th. Finally, Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The stock was bought at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the purchase, the director directly owned 375,390 shares of the company's stock, valued at $10,191,838.50. The trade was a 10.61% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Timothy P. Sullivan purchased 20,000 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The stock was purchased at an average price of $27.51 per share, with a total value of $550,200.00. Following the purchase, the director directly owned 49,229 shares of the company's stock, valued at $1,354,289.79. The trade was a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.64% of the stock is owned by insiders.

Institutional Trading of Option Care Health

Several institutional investors and hedge funds have recently bought and sold shares of the business. Thrivent Financial for Lutherans raised its position in Option Care Health by 7.1% during the 2nd quarter. Thrivent Financial for Lutherans now owns 42,730 shares of the company's stock worth $1,388,000 after buying an additional 2,829 shares during the last quarter. State of Wyoming increased its stake in shares of Option Care Health by 1.8% during the second quarter. State of Wyoming now owns 25,135 shares of the company's stock worth $816,000 after acquiring an additional 436 shares during the period. Nomura Holdings Inc. acquired a new position in shares of Option Care Health during the second quarter worth about $449,000. Castleark Management LLC increased its stake in shares of Option Care Health by 146.6% during the second quarter. Castleark Management LLC now owns 147,760 shares of the company's stock worth $4,799,000 after acquiring an additional 87,840 shares during the period. Finally, Tower Research Capital LLC TRC increased its stake in shares of Option Care Health by 373.1% during the second quarter. Tower Research Capital LLC TRC now owns 31,207 shares of the company's stock worth $1,014,000 after acquiring an additional 24,611 shares during the period. Hedge funds and other institutional investors own 98.05% of the company's stock.

Option Care Health Stock Performance

Shares of OPCH traded up $0.23 during trading hours on Friday, hitting $28.67. The stock had a trading volume of 646,138 shares, compared to its average volume of 1,853,025. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The firm has a 50-day moving average price of $29.47 and a 200 day moving average price of $31.61. The firm has a market capitalization of $4.65 billion, a price-to-earnings ratio of 22.95, a PEG ratio of 1.75 and a beta of 0.82. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. The company had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The firm's revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, research analysts anticipate that Option Care Health will post 1.22 EPS for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.